Company Overview and News
TAIPEI – From streetside stalls dishing out one dollar bowls of braised pork rice to upscale eateries tucked away in quiet alleyways, Michelin inspectors are scouring the Taiwanese capital selecting restaurants for its first ever guide.
This picture taken on October 30, 2017 shows a chef of Shin Yeh restaurant cooking in the kitchen in Taipei. From streetside stalls dishing out one dollar bowls of braised pork rice to upscale eateries tucked away in quiet alleyways, Michelin inspectors are scouring the Taiwanese capital selecting restaurants for its first ever guide. AFP
TAIPEI: From streetside stalls dishing out one dollar bowls of braised pork rice to upscale eateries tucked away in quiet alleyways, Michelin inspectors are scouring the Taiwanese capital selecting restaurants for its first ever guide.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
MONTEREY, Calif., Aug. 8, 2017 /PRNewswire/ -- Michelin is expanding its presence at Monterey Car Week, an event that is renowned as one of the world's most prestigious and exclusive venues for automotive enthusiasts. Michelin's multiple exhibits will feature rare and exhilarating vehicles from among the Company's most inspiring and collaborative relationships: Koenigsegg, Ferrari, Ford, Mercedes-Benz and Porsche.
Manila is fast becoming a city of “stars,” thanks to entrepreneurs who are shaking the local food scene with the entry of Michelin-starred restaurants.
Good day and welcome to the Q1 2017 Financial Results Conference call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Miss. Kerstin Heinrich, please go ahead.
GREENVILLE, S.C., April 7, 2017 /PRNewswire/ -- The Rubber Manufacturers Association (RMA) has presented nine of its 16 safety awards this year to Michelin manufacturing plants in the United States.
Paris, France 9th February 2017 – Following the announcement of the 2017 Michelin Guide, the restaurants Le Cinq, Le George and L’Orangerie at the Four Seasons Hotel George V, Paris have collectively been crowned with a total of five Michelin stars, making the acclaimed Hotel the first luxury Hotel in Europe to be home to three Michelin-starred restaurants.
GREENVILLE, SC and DEERFIELD BEACH, FL--(Marketwired - December 29, 2016) - As people set resolutions for 2017, Michelin reminds drivers to make safe driving a priority in the new year. For optimum vision and the safest driving experience, Michelin recommends changing wiper blades.
FORESTVILLE, Calif., Dec. 28, 2016 /PRNewswire/ -- The Farmhouse Inn, Sonoma's premier boutique luxury hotel, is pleased to announce the Icons of the Russian River Valley package, offering locals and visitors alike a taste of the best of Sonoma Wine Country. A new world cousin to France's Burgundy; the Russian River Valley in Sonoma wine country is home to some of the best Pinot Noirs and Chardonnays in the world.
GREENVILLE, SC and DEERFIELD BEACH, FL--(Marketwired - December 16, 2016) - Michelin wants to keep drivers safe by reminding them to change their wiper blades before winter weather sets in. For optimum visibility and the safest driving experience, Michelin recommends MICHELIN® Stealth® Hybrid® wiper blades with exclusive Smart-Flex™ Technology.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...